参考文献
［1］ van der Meer P，Gaggin HK，Dec GW.ACC／AHA versus ESC guidelines on heart failure：JACC guideline comparison［J］.J Am Coll Cardiol，2019，73：2756-2768.
［2］ Habal MV，Garan AR.Long-term management of end-stage heart failure［J］.Best Pract Res Clin Anaesthesiol，2017，31：153-166.
［3］ Kida K，Doi S，Suzuki N.Palliative care in patients with advanced heart failure［J］.Heart Fail Clin，2020，16：243-254.
［4］ Lowey SE.Palliative care in the management of patients with advanced heart failure［J］.Adv Exp Med Biol，2018，1067：295-311.
［5］ Melillo E，Masarone D，Oh JK，et al.Echocardiography in advanced heart failure for diagnosis，management，and prognosis［J］.Heart Fail Clin，2021，17：547-556.
［6］ Janssen DJ，Ament SM，Boyne J，et al.Characteristics for a tool for timely identification of palliative needs in heart failure：The views of Dutch patients，their families and healthcare professionals［J］.Eur J Cardiovasc Nurs，2020，19：711-720.
［7］ Higginbotham K，Jones I，Johnson M.A grounded theory study：Exploring health care professionals decision making when managing end stage heart failure care［J］.J Adv Nurs，2021，77：3142-3155.
［8］ Sumler M，Vadlamudi R.Preanesthetic evaluation of the patient with end-stage heart failure［J］.Best Pract Res Clin Anaesthesiol，2017，31：179-188.
［9］ Wong FK，Ng AY，Lee PH，et al.Effects of a transitional palliative care model on patients with end-stage heart failure：A randomised controlled trial［J］.Heart，2016，102：1100-1108.
［10］ Chester R，Richardson H，Doyle C，et al.Heart failure-the experience of living with end-stage heart failure and accessing care across settings［J］.Ann Palliat Med，2021，10：7416-7427.
［11］ Grant JS，Graven LJ.Problems experienced by informal caregivers of individuals with heart failure：An integrative review［J］.Int J Nurs Stud，2018，80：41-66.
［12］ Cutshall BT，Duhart BT Jr，Saikumar J，et al.Assessing guideline-directed medication therapy for heart failure in end-stage renal disease［J］.Am J Med Sci，2018，355：247-251.(https://www.daowen.com)
［13］ Martens P，Vercammen J，Ceyssens W，et al.Effects of intravenous home dobutamine in palliative end-stage heart failure on quality of life，heart failure hospitalization，and cost expenditure［J］.ESC Heart Fail，2018，5：562-569.
［14］ Grubb CS，Truby LK，Topkara VK，et al.Advanced heart failure patients supported with ambulatory inotropic therapy：What defines success of therapy［J］.Am Heart J，2021，239：11-18.
［15］ Mullan CW，Sen S，Ahmad T.Left ventricular assist devices versus heart transplantation for end stage heart failure is a misleading equivalency［J］.JACC Heart Fail，2021，9：290-292.
［16］ Sobanski PZ，Alt-Epping B，Currow DC，et al.Palliative care for people living with heart failure：Europeanassociation for palliative care task force expert position statement［J］.Cardiovasc Res，2020，116：12-27.
［17］ Mechler K，Liantonio J.Palliative care approach to chronic diseases：End stages of heart failure，chronic obstructive pulmonary disease，liver failure，and renal failure［J］.Prim Care，2019，46：415-432.
［18］ Anscombe R，Middlemiss T.Palliative care in end-stage heart failure：experience of a collaborative approach in a secondary care setting［J］.Intern Med J，2019，49：404-407.
［19］ Tatum PE，Mills SS.Hospice and palliative care：An overview［J］.Med Clin North Am，2020，104：359-373.
［20］ Hyden K，Gelfman L，Dionne-Odom JN，et al.Update in hospice and palliative care［J］.J Palliat Med，2020，23：165-170.
［21］ Burnside L，Whyte S，Cooper SG.Advanced heart failure treatment modalities and hospice care：The need for high level care coordination［J］.Am J Hosp Palliat Care，2019，36：812-814.
［22］ Diamant MJ，Keshmiri H，Toma M.End-of-life care in patients with advanced heart failure［J］.Curr Opin Cardiol，2020，35：156-161.
［23］ Ayach B，Malik A，Seifer C，et al.End of life decisions in heart failure：To turn off the intracardiac device or not［J］.Curr Opin Cardiol，2017，32：224-228.
［24］ Cheung WY，Schaefer K，May CW，et al.Enrollment and events of hospice patients with heart failure vs.cancer［J］.JPain Symptom Manage，2013，45：552-560.